<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Multiparametric Tissue Characterization of Brain Neoplasms and Their Recurrence Using Pattern Classification of MR Images" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/multiparametric-tissue-characterization-of-brain-neoplasms-and-their-recurrence-using-pattern-classi/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/multiparametric-tissue-characterization-of-brain-neoplasms-and-their-recurrence-using-pattern-classi/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2008-07-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Multiparametric Tissue Characterization of Brain Neoplasms and Their Recurrence Using Pattern Classification of MR Images" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-07T07:15:32+00:00","datePublished":"2008-07-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Multiparametric Tissue Characterization of Brain Neoplasms and Their Recurrence Using Pattern Classification of MR Images","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/multiparametric-tissue-characterization-of-brain-neoplasms-and-their-recurrence-using-pattern-classi/"},"url":"https://clinicaltree.github.io/posts/multiparametric-tissue-characterization-of-brain-neoplasms-and-their-recurrence-using-pattern-classi/"}</script><title>Multiparametric Tissue Characterization of Brain Neoplasms and Their Recurrence Using Pattern Classification of MR Images | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Multiparametric Tissue Characterization of Brain Neoplasms and Their Recurrence Using Pattern Classification of MR Images</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Multiparametric Tissue Characterization of Brain Neoplasms and Their Recurrence Using Pattern Classification of MR Images</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1217523600" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Jul 31, 2008 </em> </span> <span> Updated <em class="" data-ts="1680851732" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 7, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Ragini Verma PhD</a> </em>, <em> <a href="">Evangelia I. Zacharaki PhD</a> </em>, <em> <a href="">Yangming Ou</a> </em>, <em> <a href="">Hongmin Cai</a> </em>, <em> <a href="">Sanjeev Chawla PhD</a> </em>, <em> <a href="">Seung-Koo Lee MD</a> </em>, <em> <a href="">Elias R. Melhem PhD MD</a> </em>, <em> <a href="">Ronald Wolf MD</a> </em>, <em> <a href="">Christos Davatzikos PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2131 words"> <em>11 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Treatment of brain neoplasms can greatly benefit from better delineation of bulk neoplasm boundary and the extent and degree of more subtle neoplastic infiltration. Magnetic resonance imaging (MRI) is the primary imaging modality for evaluation before and after therapy, typically combining conventional sequences with more advanced techniques such as perfusion-weighted imaging and diffusion tensor imaging (DTI). The purpose of this study is to quantify the multiparametric imaging profile of neoplasms by integrating structural MRI and DTI via statistical image analysis methods to potentially capture complex and subtle tissue characteristics that are not obvious from any individual image or parameter.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Five structural MRI sequences, namely, B0, diffusion-weighted images, fluid-attenuated inversion recovery, T1-weighted, and gadolinium-enhanced T1-weighted, and two scalar maps computed from DTI (ie, fractional anisotropy and apparent diffusion coefficient) are used to create an intensity-based tissue profile. This is incorporated into a nonlinear pattern classification technique to create a multiparametric probabilistic tissue characterization, which is applied to data from 14 patients with newly diagnosed primary high-grade neoplasms who have not received any therapy before imaging.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Preliminary results demonstrate that this multiparametric tissue characterization helps to better differentiate among neoplasm, edema, and healthy tissue, and to identify tissue that is likely to progress to neoplasm in the future. This has been validated on expert assessed tissue.</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>This approach has potential applications in treatment, aiding computer-assisted surgery by determining the spatial distributions of healthy and neoplastic tissue, as well as in identifying tissue that is relatively more prone to tumor recurrence.</p><p>Treatment of brain neoplasms varies with their type, grade, location, and extent, and often includes a combination of surgical resection and chemoradiation. This can greatly benefit from better delineation of bulk neoplasm boundary, as well as knowledge of the extent and degree of neoplastic infiltration. The true boundary of many neoplasms is difficult to identify with conventional approaches, especially in gliomas that are diffuse and infiltrative. Relatively advanced imaging strategies, such as perfusion-weighted imaging (PWI), magnetic resonance spectroscopy (MRS), and diffusion tensor imaging (DTI), have improved evaluation in this regard, but remain limited. Tissue characterization is difficult because neoplasms are often heterogeneous, and different histopathologic grades can be present throughout an individual neoplasm. Because the treatment planning of brain neoplasms typically seeks to reduce risk for severe functional loss, large portions of brain neoplasms may remain untreated or suboptimally treated such that time to recurrence shortens and prognosis worsens.</p><p>Clinical decisions regarding glioma treatments rely, in part, on magnetic resonance imaging (MRI) before and after surgery as well as follow-up during and after chemoradiation. Routine MRI sequences such as fluid-attenuated inversion recovery (FLAIR) and contrast-enhanced T1-weighted MR images are used to obtain estimates of enhancing and nonenhancing tissue, as well as of edema (ED) or gliosis. However, this process is time and labor intensive, susceptible to inter-rater variability, and often inaccurate, especially in the setting of treatment-related necrosis versus recurrence/progression. Clinical decision making has been aided by the efforts of the medical image analysis community in developing MRI-based automated tumor detection and segmentation ( ).</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="data-acquisition"><span class="mr-2">Data Acquisition</span><a href="#data-acquisition" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="creation-of-tissue-abnormality-map"><span class="mr-2">Creation of tissue abnormality map</span><a href="#creation-of-tissue-abnormality-map" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricTissueCharacterizationofBrainNeoplasmsandTheirRecurrenceUsingPatternClassificationofMRImages/0_1s20S1076633208001402.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricTissueCharacterizationofBrainNeoplasmsandTheirRecurrenceUsingPatternClassificationofMRImages/0_1s20S1076633208001402.jpg" alt="Figure 1, A representative slice from each of the seven co-registered magnetic resonance modalities used in creating the multimodality tissue profile. ADC, apparent diffusion coefficient; B0, baseline (T2-weighted); DWI, diffusion weighted image; FA, fractional anisotropy; FLAIR, fluid attenuated inversion recovery; GAD, gadolinum-enhanced T1-weighted; T1, T1-weighted." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="creation-of-recurrence-maps"><span class="mr-2">Creation of recurrence maps</span><a href="#creation-of-recurrence-maps" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><ul><li><p>1 <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p>2 <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><li><p>3 <a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p></ul><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="preprocessing"><span class="mr-2">Preprocessing</span><a href="#preprocessing" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="design-of-tissue-abnormality-feature-vector"><span class="mr-2">Design of Tissue Abnormality Feature Vector</span><a href="#design-of-tissue-abnormality-feature-vector" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>vx→−→=[I(ADC)x→,I(B0)x→,I(DWI)x→,I(FA)x→,I(FLAIR)x→,I(T1)x→,I(GAD)x→]T v</p><p>x</p><p>→</p><p>→</p><p>=</p><p>[</p><p>I</p><p>x</p><p>→</p><p>(</p><p>A</p><p>D</p><p>C</p><p>)</p><p>,</p><p>I</p><p>x</p><p>→</p><p>(</p><p>B</p><p>0</p><p>)</p><p>,</p><p>I</p><p>x</p><p>→</p><p>(</p><p>D</p><p>W</p><p>I</p><p>)</p><p>,</p><p>I</p><p>x</p><p>→</p><p>(</p><p>F</p><p>A</p><p>)</p><p>,</p><p>I</p><p>x</p><p>→</p><p>(</p><p>F</p><p>L</p><p>A</p><p>I</p><p>R</p><p>)</p><p>,</p><p>I</p><p>x</p><p>→</p><p>(</p><p>T</p><p>1</p><p>)</p><p>,</p><p>I</p><p>x</p><p>→</p><p>(</p><p>G</p><p>A</p><p>D</p><p>)</p><p>]</p><p>T</p><p>where I(M)x→ I</p><p>x</p><p>→</p><p>(</p><p>M</p><p>) denotes the intensity of image of modality <em>M</em> at voxel x→ x</p><p>→ . These feature vectors are defined at each voxel in the training samples. To render this feature vector more robust to noise, we incorporate neighborhood information by using four of its neighbors. Seven-dimensional intensity features for these 5 voxels are stacked into a long vector (35-dimensional), which is then used as a feature vector.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="selection-of-the-training-samples"><span class="mr-2">Selection of the training samples</span><a href="#selection-of-the-training-samples" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricTissueCharacterizationofBrainNeoplasmsandTheirRecurrenceUsingPatternClassificationofMRImages/1_1s20S1076633208001402.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricTissueCharacterizationofBrainNeoplasmsandTheirRecurrenceUsingPatternClassificationofMRImages/1_1s20S1076633208001402.jpg" alt="Figure 2, Intrapatient Bayesian classification framework applied to three patients. Each row corresponds to a patient. Columns 1–2 show examples of training samples conservatively chosen by the expert for tissues samples of edema (ED), enhancing neoplasm/tumor (ET), or nonenhancing neoplasm/tumor (NET). Columns 3–5 are the probability maps for ED, NET, and ET, respectively. The numbers in the upper left corners denote the classification rates after segmentation (see column 6). A missing image such as in ( 2 4 ) block indicates the lack of training samples for that tissue class and hence the inability of the classifier to produce the corresponding probability map. The color bar for the probability maps are in block ( 2 4 ). Column 6 shows the segmented image with the color coding of the tissues shown next to the color bar." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="creation-of-tissue-classifiers-and-tissue-probability-maps"><span class="mr-2">Creation of tissue classifiers and tissue probability maps</span><a href="#creation-of-tissue-classifiers-and-tissue-probability-maps" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="intrapatient-classification"><span class="mr-2">Intrapatient Classification</span><a href="#intrapatient-classification" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="interpatient-classification"><span class="mr-2">Interpatient Classification</span><a href="#interpatient-classification" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="design-of-recurrence-map"><span class="mr-2">Design of Recurrence Map</span><a href="#design-of-recurrence-map" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricTissueCharacterizationofBrainNeoplasmsandTheirRecurrenceUsingPatternClassificationofMRImages/2_1s20S1076633208001402.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricTissueCharacterizationofBrainNeoplasmsandTheirRecurrenceUsingPatternClassificationofMRImages/2_1s20S1076633208001402.jpg" alt="Figure 3, Maps of tumor recurrence for three cases. For each case, the top row shows postresection scans; green arrows point to regions identified as suspected of possible recurrence. Bottom row, left : Preresection scans showing the regions used for training; blue are samples for healthy tissue; burgundy are some of the regions identified by an expert as having recurrence in postresection scans when combined with cues obtained from elastic registration. Bottom row, right : Probability maps using interpatient classifiers that provide a voxel-wise map of likelihood of tumor recurrence. The color bar is the same as that of Fig. 2 with red indicating higher degree of abnormality. Red arrows are used to indicate regions in which recurrence actually occurred in follow-up scans." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="intrapatient-tissue-classification"><span class="mr-2">Intrapatient Tissue Classification</span><a href="#intrapatient-tissue-classification" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Average ( <em>avg</em> ) Classification Rates and their Standard Deviation ( <em>stdev</em> ) of the Classification Rates, Sensitivity, and Specificity, Over All Subjects for Intrapatient and Interpatient Framework Using Bayesian and SVM Classifications</p><p>Classification Rates Sensitivity Tumor vs. Healthy Specificity Tumor vs. Healthy ED ET NET CSF GM WM Bayesian classification (intrapatient)<em>Avg</em> 97.03 96.39 93.05 89.68 74.86 82.95 91.84 99.57<em>Stdev</em> 3.18 3.4 11.82 21.72 6.95 7.73 6.01 0.63 Bayesian classification (interpatient)<em>Avg</em> 53.86 86.56 51.11 82.31 66.78 76.06 75.62 94.57<em>Stdev</em> 47.59 27.74 43.86 15.82 9.22 15.05 36.14 6.12 SVM classification (interpatient)<em>Avg</em> 93.38 88.79 34.01 91.34 72.21 85.33 87.54 97.03<em>Stdev</em> 8.75 29.03 38.71 7.9 12.08 9.45 15.58 3.26</p><p>CSF, cerebrospinal fluid; ED, edema; ET, enhancing neoplasm/tumor; GM, gray matter; NET, nonenhancing neoplasm/tumor; SVM, support vector machines; WM, white matter.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="interpatient-tissue-classification"><span class="mr-2">Interpatient Tissue Classification</span><a href="#interpatient-tissue-classification" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricTissueCharacterizationofBrainNeoplasmsandTheirRecurrenceUsingPatternClassificationofMRImages/3_1s20S1076633208001402.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricTissueCharacterizationofBrainNeoplasmsandTheirRecurrenceUsingPatternClassificationofMRImages/3_1s20S1076633208001402.jpg" alt="Figure 4, Application of SVM classification ( top row ) and Bayesian classification ( bottom row ) of the neoplasm represented in column 1 by training across patients. Although support vector machines (SVM) classifiers combining information from several patients are able to identify both edema (ED) and nonenhancing neoplasm/tumor (NET), like the expert, the Bayesian classifiers created from this patient alone identify the whole neoplastic region as NET (unlike the expert). The color coding is same as that of Fig. 2 . FLAIR, fluid attenuated inversion recovery; GAD, gadolinium-enhanced T1-weighted." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricTissueCharacterizationofBrainNeoplasmsandTheirRecurrenceUsingPatternClassificationofMRImages/4_1s20S1076633208001402.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/MultiparametricTissueCharacterizationofBrainNeoplasmsandTheirRecurrenceUsingPatternClassificationofMRImages/4_1s20S1076633208001402.jpg" alt="Figure 5, Application of support vector machines (SVM) classification ( top row ) and Bayesian classification ( bottom row ) of the neoplasm represented in column 1 by training across patients using training samples shown in column 2. The SVM classification ( top row, columns 3–6 ) is more conservative than the Bayesian classification ( bottom row, columns 3–6 ) and better matches the expert. The probability maps using the Bayesian classification seem to identify the edema (ED) well, oversegment the enhancing neoplasm/tumor (ET), and confuse the nonenhancing neoplasm/tumor (NET) with cerebrospinal fluid (CSF). The SVM classification is able to capture the presence of NET ( green ) in the segmented image on top row, along with ED and ET. The color coding is same as that of Fig. 2 . FLAIR, fluid attenuated inversion recovery; GAD, gadolinium-enhanced T1-weighted." class="lazyload" data-proofer-ignore></a></p><p>Table 2</p><p>Classification Rates Sensitivity and Specificity of Applying the SVM and Bayesian Interpatient Classification Framework to the Two Patients Shown in Figures 4 and 5</p><p>Patient in Figure Classification Rates Sensitivity Tumor vs. Healthy Specificity Tumor vs. Healthy ED ET NET CSF GM WM Fig. 4 SVM 79.78 NA 56.61 78.11 81.99 84.36 71.07 99.49 Bayes 2.28 NA 100 37.01 56.25 60.58 99.98 77.6 Fig. 5 SVM 100 11.56 NA 99.9 54.66 96.16 81.59 99.97 Bayes 100 99.03 NA 97.87 72.84 61.26 99.02 98.11</p><p>CSF, cerebrospinal fluid; ED, edema; ET, enhancing neoplasm/tumor; GM, gray matter; NET, nonenhancing neoplasm/tumor; SVM, support vector machines; WM, white matter.</p><p>Overall, the SVM classification performs better than the Bayesian. The low classification rates of healthy tissue are due to these samples being selected through an automated segmentation method, which may have led to errors in training.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="analyzing-patterns-of-tumor-recurrence"><span class="mr-2">Analyzing Patterns of Tumor Recurrence</span><a href="#analyzing-patterns-of-tumor-recurrence" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Prastawa M., Bullitt E., Ho S., et. al.: A brain tumor segmentation framework based on outlier detection. Med Image Anal 2004; 8: pp. 275-283.</p><li><p>2. Schmidt M, Levner I, Greiner R, et al. Segmenting brain tumors using alignment-based features. The Fourth International Conference on Machine Learning and Applications, Los Angeles, CA, December 2005.</p><li><p>3. Kaus M.R., Warfield S.K., Nabavi A., et. al.: Automated segmentation of MR images of brain tumors. Radiology 2001; 218: pp. 586-591.</p><li><p>4. Just M., Thelen M.: Tissue characterization with T1, T2 and proton density values: results in 160 patients with brain tumors. Radiology 1988; 169: pp. 779-785.</p><li><p>5. Fletcher-Heath L.M., Hall L.O., Goldgof D.B., et. al.: Automatic segmentation of non-enhancing brain tumors in magnetic resonance images. Artif Intell Med 2001; 21: pp. 43-63.</p><li><p>6. Clark M., Hall L., Goldgof D., et. al.: Automatic tumor segmentation using knowledge-based techniques. IEEE Trans Med Imaging 1998; 17: pp. 187-201.</p><li><p>7. Young R.J., Knopp E.A.: Brain MRI: tumor evaluation. J Magn Res Imaging 2006; 24: pp. 709-724.</p><li><p>8. Bordignon K.C., Neto M.C., Ramina R., et. al.: Patterns of neuroaxis dissemination of gliomas: suggestion of a classification based on magnetic resonance imaging findings. Surg Neurol 2006; 65: pp. 472-477.</p><li><p>9. Talos I.-F., Zou K.H., Ohno-Machado L., et. al.: Supratentorial low grade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristics. Radiology 2006; 239: pp. 506-513.</p><li><p>10. Aronen H.J., Gazit I.E., Louis D.N., et. al.: Cerebral blood volume maps of gliomas: comparison with tumor grade and histological findings. Radiology 1994; 191: pp. 41-51.</p><li><p>11. Krabbe K., Gideon P., Wagn P., et. al.: MR diffusion imaging of human intracranial tumors. Neuroradiology 1997; 39: pp. 483-489.</p><li><p>12. Provenzale J.M., Mukundan S., Baroriak D.P.: Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment. Radiology 2006; 239: pp. 632-649.</p><li><p>13. Bihan D.L., Mangin J.-F., Poupon C., et. al.: Diffusion tensor imaging: concepts and applications. J Magnet Reson Imaging 2001; 13: pp. 534-546.</p><li><p>14. Nimsky C., Ganslandt O., Hastreiter P., et. al.: Intraoperative diffusion tensor MR imaging: shifting of white matter tracts during neuro-surgical procedures—initial experience. Radiology 2005; 234: pp. 218-225.</p><li><p>15. Field A.S., Alexander A.L.: Diffusion tensor imaging in cerebral tumor diagnosis and therapy. Top Magnet Reson Imaging 2004; 15: pp. 315-324.</p><li><p>16. Stieltjes B., Schluter M., Didinger B., et. al.: Diffusion tensor imaging in primary brain tumors: reproducible quantitative analysis of corpus callosum infiltration and contralateral involvement using a probabilistic mixture model. Neuroimage 2006; 31: pp. 531-542.</p><li><p>17. Stadlbauer A., Nimsky C., Buslei R., et. al.: Diffusion tensor imaging and optimized fiber tracking in glioma patients: histopathologic evaluation of tumor-invaded white matter structures. Neuroimage 2007; 34: pp. 949-956.</p><li><p>18. Tummala R.P., Chu R.M., Liu H., et. al.: Application of diffusion tensor imaging to magnetic-resonance-guided brain tumor resection. Pediatr Neurosurg 2003; 39: pp. 39-43.</p><li><p>19. Mori S., Fredericksen K., Zijl P.C.M., et. al.: Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging. Ann Neurol 2002; 51: pp. 377-380.</p><li><p>20. Jellison B.J., Field A.S., Medow J., et. al.: Diffusion tensor imaging of cerebral white matter: a pictorial review of physics, fiber tract anatomy, and tumor imaging patterns. Am J Neuroradiol 2004; 25: pp. 356-369.</p><li><p>21. Sundgren P.C., Fan X., Weybright P., et. al.: Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions. Magnet Reson Imaging 2006; 24: pp. 1131-1142.</p><li><p>22. Hein P.A., Eskey C.J., Dunn J.F., et. al.: Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 2004; 25: pp. 201-209.</p><li><p>23. Smith S.M., Jenkinson M., Woolrich M.W., et. al.: Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004; 23: pp. 208-219.</p><li><p>24. Jenkinson M., Smith S.: A global optimisation method for robust affine registration of brain images. Med Image Anal 2001; 5: pp. 143-156.</p><li><p>25. Zacharaki E.I., Shen D., Mohamed A., et. al.: Registration of brain images with tumors: towards the construction of statistical atlases for therapy planning.2006.ISBIArlington, VA</p><li><p>26. Zhang Y., Brady M., Smith S.: Segmentation of brain MR images through a hidden Markov random field model and the expectation maximization algorithm. IEEE Trans Med Imaging 2001; 20: pp. 45-57.</p><li><p>27. Schölkopf B., Smola A.J.: Learning with kernels: support vector machines, regularization, optimization and beyond (adaptive computation and machine learning).2001.The MIT PressCambridge, MA</p><li><p>28. LaConte S., Strother S., Cherkassky V., et. al.: Support vector machines for temporal classification of block design fMRI data. NeuroImage 2005; 26: pp. 317-329.</p><li><p>29. Davatzikos C., Shen D.G., Wu X., et. al.: Whole-brain morphometric study of schizophrenia reveals a spatially complex set of focal abnormalities. JAMA Arch Gen Psychiatry 2005; 62: pp. 1218-1227.</p><li><p>30. McLachlan G.J.: Discriminant analysis and statistical pattern recognition.2004.Wiley-InterscienceNew York (Wiley Series in Probability and Statistics).</p><li><p>31. Platt J.: Probabilistic outputs for support vector machines and comparison to regularized likelihood methods.Smola A.J.Bartlett P.Schölkop B.Schuúrmans D.Advances in large margin classifiers.2000.MIT PressCambridge, MA:pp. 61-74.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-15/'>Volume 15</a>, <a href='/categories/issue-8/'>Issue 8</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Multiparametric%20Tissue%20Characterization%20of%20Brain%20Neoplasms%20and%20Their%20Recurrence%20Using%20Pattern%20Classification%20of%20MR%20Images%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmultiparametric-tissue-characterization-of-brain-neoplasms-and-their-recurrence-using-pattern-classi%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Multiparametric%20Tissue%20Characterization%20of%20Brain%20Neoplasms%20and%20Their%20Recurrence%20Using%20Pattern%20Classification%20of%20MR%20Images%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmultiparametric-tissue-characterization-of-brain-neoplasms-and-their-recurrence-using-pattern-classi%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fmultiparametric-tissue-characterization-of-brain-neoplasms-and-their-recurrence-using-pattern-classi%2F&text=Multiparametric%20Tissue%20Characterization%20of%20Brain%20Neoplasms%20and%20Their%20Recurrence%20Using%20Pattern%20Classification%20of%20MR%20Images%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/abstracts-of-funded-national-institutes-of-health-grants/"><div class="card-body"> <em class="small" data-ts="1217523600" data-df="ll" > Jul 31, 2008 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Abstracts of Funded National Institutes of Health Grants</h3><div class="text-muted small"><p> The following abstracts of diagnostic radiology research and training grants funded by the National Institutes of Health (NIH) were awarded to principal investigators (PIs) whose primary appointmen...</p></div></div></a></div><div class="card"> <a href="/posts/assessment-of-pancreatic-tumor-resectability-with-multidetector-computed-tomography/"><div class="card-body"> <em class="small" data-ts="1217523600" data-df="ll" > Jul 31, 2008 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Assessment of Pancreatic Tumor Resectability with Multidetector Computed Tomography</h3><div class="text-muted small"><p> Rationale and Objectives The purpose of this retrospective study was to compare the maximum intensity projection (MIP) images generated at a multidetector computed tomography (MDCT) scanner consol...</p></div></div></a></div><div class="card"> <a href="/posts/classification-of-parenchymal-abnormality-in-scleroderma-lung-using-a-novel-approach-to-denoise-imag/"><div class="card-body"> <em class="small" data-ts="1217523600" data-df="ll" > Jul 31, 2008 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Classification of Parenchymal Abnormality in Scleroderma Lung Using a Novel Approach to Denoise Images Collected via a Multicenter Study</h3><div class="text-muted small"><p> Rationale and Objectives Computerized classification techniques have been developed to offer accurate and robust pattern recognition in interstitial lung disease using texture features. However, t...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/make-a-stink/" class="btn btn-outline-primary" prompt="Older"><p>Make a stink</p></a> <a href="/posts/registration-methodology-for-histological-sections-and-in-vivo-imaging-of-human-prostate/" class="btn btn-outline-primary" prompt="Newer"><p>Registration Methodology for Histological Sections and In Vivo Imaging of Human Prostate</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
